Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis with
or without pregnancy morbidity in the presence of autoantibodies targeting proteins that …

The antiphospholipid syndrome (APS) is an autoimmune systemic disease characterized by
a hypercoagulable state secondary to the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is characterised by vascular thrombosis and/or obstetric
morbidity in the presence of persistently positive antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically
characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the …

Persistent serum positivity for antiphospholipid antibodies (aPL) is required to diagnose
antiphospholipid syndrome (APS), an autoimmune disease characterized by recurrent …

Antiphospholipid syndrome (APS) is the most common acquired thrombophilia. The clinical
manifestations of APS are mainly vascular thrombosis (venous and/or arterial) and/or …

Antiphospholipid syndrome (APS) is a clinical syndrome characterized by macro-and/or
microvascular thrombosis and pregnancy morbidity, with laboratory criteria including …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by the
persistent positivity of antiphospholipid antibodies (aPLA) together with thrombosis or …

For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …